M. M. A. Shalahuddin Qusar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
M. M. A. Shalahuddin Qusar has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Rabiul Islam
School of Pharmacy BRAC University Dhaka Bangladesh
5 shared publications - A. H. M. Mostofa Kamal
Department of Psychiatry Bangladesh Medical University Dhaka Bangladesh
1 shared publication - A. S. M. Roknuzzaman
Department of Pharmacy University of Asia Pacific Dhaka Bangladesh
1 shared publication - Abul Hasnat
University of Dhaka
1 shared publication Ashrafur Rahman
Department of Clinical Pharmacy and Pharmacology, Faculty of Pharmacy, University of Dhaka, Dhaka, 1000, Bangladesh
1 shared publicationF Rahman
1 shared publication
Latest Publications
- Open Access
- 22 September 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (10) , e73269
Prevalence and Associated Risk Factors of Psychiatric Comorbidities Among the Hospitalized Patients in Bangladesh: A Cross‐Sectional Study
Background: Patients with chronic illnesses frequently experience social isolation and physical disability, which may adversely affect their mental health. Studies investigating the prevalence and associated risk factors are limited. Therefore, we aimed to measure the prevalence and associated risk factors of psychiatric comorbidities among hospitalized patients in Bangladesh. Methods: This was a face‐to‐face interview and medical record review study conducted at a tertiary care teaching hospital. A qualified psychiatrist evaluated 342 admitted patients according to DSM‐5 criteria. Several statistical methods were applied to determine the prevalence of psychiatric comorbidities and their associated factors among hospitalized patients. Results: About half of the patients were diagnosed with at least one psychiatric disorder. The highest prevalence was observed in oncology, followed by medicine, surgery, and neurology. In multivariable analysis, a history of mental illness and hospitalized department were significantly associated with psychiatric comorbidity, with the strongest association observed among oncology patients compared with surgery patients. Depressive and anxiety disorders were the most frequent psychiatric comorbidities. Conclusions: This study highlights the high prevalence of psychiatric comorbidities among hospitalized patients. Mental health screening, interventions, and psychosocial support may facilitate early identification and management of psychiatric comorbidities. Our findings support strengthening mental health screening and psychiatric assessment among hospitalized patients. Where feasible, consultation‐liaison psychiatry services may help improve mental health care in hospital settings.
- 22 September 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (10) , e73269
Open AccessPrevalence and Associated Risk Factors of Psychiatric Comorbidities Among the Hospitalized Patients in Bangladesh: A Cross‐Sectional Study
Background: Patients with chronic illnesses frequently experience social isolation and physical disability, which may adversely affect their mental health. Studies investigating the prevalence and associated risk factors are limited. Therefore, we aimed to measure the prevalence and associated risk factors of psychiatric comorbidities among hospitalized patients in Bangladesh. Methods: This was a face‐to‐face interview and medical record review study conducted at a tertiary care teaching hospital. A qualified psychiatrist evaluated 342 admitted patients according to DSM‐5 criteria. Several statistical methods were applied to determine the prevalence of psychiatric comorbidities and their associated factors among hospitalized patients. Results: About half of the patients were diagnosed with at least one psychiatric disorder. The highest prevalence was observed in oncology, followed by medicine, surgery, and neurology. In multivariable analysis, a history of mental illness and hospitalized department were significantly associated with psychiatric comorbidity, with the strongest association observed among oncology patients compared with surgery patients. Depressive and anxiety disorders were the most frequent psychiatric comorbidities. Conclusions: This study highlights the high prevalence of psychiatric comorbidities among hospitalized patients. Mental health screening, interventions, and psychosocial support may facilitate early identification and management of psychiatric comorbidities. Our findings support strengthening mental health screening and psychiatric assessment among hospitalized patients. Where feasible, consultation‐liaison psychiatry services may help improve mental health care in hospital settings.
- 25 March 2026
- Published by Wiley in Developmental Neurobiology
- Vol. 86 (2) , e70025
Exploring the Role of Altered Serum IL‐12 and CRP Levels in the Pathophysiology and Development of Generalized Anxiety Disorder: A Cross‐Sectional Comparative Study
Cytokines and immune imbalance in generalized anxiety disorder (GAD) have attracted greater interest of all researchers. Studies indicate the involvement of pro‐inflammatory cytokines in the pathogenesis of GAD. Therefore, the present study investigated the serum concentrations of interleukin (IL)‐12 and carbon‐reactive protein (CRP) in GAD patients to explore their role in the pathophysiology of diseases. This study included 52 GAD patients and 30 healthy controls (HCs) matched by age and sex. A psychiatrist diagnosed GAD patients and evaluated HCs according to the DSM‐5 criteria. The severity of GAD cases was assessed using a standardized and validated clinical rating scale (GAD‐7). ELISA kits were utilized to measure the serum concentrations of IL‐12 and CRP in blood. GAD patients revealed significantly elevated concentrations of IL‐12 (7.60 ± 1.53 pg/mL) than HCs (3.73 ± 0.42 pg/mL). These increased levels were positively correlated with GAD‐7 scores ( r = 0.377, p = 0.006). This IL‐12 also demonstrated strong predictive ability in the receiver operating characteristic (ROC) investigation, with an area under the curve (AUC) of 0.828 ( p < 0.001), indicating 81.6% sensitivity and 77.8% specificity at a threshold of 3.56 pg/mL. In contrast, the level of CRP was not changed between the groups (2.59 ± 0.13 vs. 2.55 ± 0.16 mg/L); furthermore, no association was detected between CRP levels and GAD‐7 scores ( r = 0.021, p = 0.881). Our investigation indicates that IL‐12 in blood levels, but not CRP, may be associated with the pathophysiology and development of GAD. The altered serum IL‐12 levels in GAD patients might be the result of disease pathogenesis. However, we recommend more advanced investigation with greater sample sizes to verify the probable diagnostic utility of IL‐12.
- 25 March 2026
- Published by Wiley in Developmental Neurobiology
- Vol. 86 (2) , e70025
Exploring the Role of Altered Serum IL‐12 and CRP Levels in the Pathophysiology and Development of Generalized Anxiety Disorder: A Cross‐Sectional Comparative Study
Cytokines and immune imbalance in generalized anxiety disorder (GAD) have attracted greater interest of all researchers. Studies indicate the involvement of pro‐inflammatory cytokines in the pathogenesis of GAD. Therefore, the present study investigated the serum concentrations of interleukin (IL)‐12 and carbon‐reactive protein (CRP) in GAD patients to explore their role in the pathophysiology of diseases. This study included 52 GAD patients and 30 healthy controls (HCs) matched by age and sex. A psychiatrist diagnosed GAD patients and evaluated HCs according to the DSM‐5 criteria. The severity of GAD cases was assessed using a standardized and validated clinical rating scale (GAD‐7). ELISA kits were utilized to measure the serum concentrations of IL‐12 and CRP in blood. GAD patients revealed significantly elevated concentrations of IL‐12 (7.60 ± 1.53 pg/mL) than HCs (3.73 ± 0.42 pg/mL). These increased levels were positively correlated with GAD‐7 scores ( r = 0.377, p = 0.006). This IL‐12 also demonstrated strong predictive ability in the receiver operating characteristic (ROC) investigation, with an area under the curve (AUC) of 0.828 ( p < 0.001), indicating 81.6% sensitivity and 77.8% specificity at a threshold of 3.56 pg/mL. In contrast, the level of CRP was not changed between the groups (2.59 ± 0.13 vs. 2.55 ± 0.16 mg/L); furthermore, no association was detected between CRP levels and GAD‐7 scores ( r = 0.021, p = 0.881). Our investigation indicates that IL‐12 in blood levels, but not CRP, may be associated with the pathophysiology and development of GAD. The altered serum IL‐12 levels in GAD patients might be the result of disease pathogenesis. However, we recommend more advanced investigation with greater sample sizes to verify the probable diagnostic utility of IL‐12.
- Open Access
- 28 February 2025
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 16 (1) , 72-80
Altered eotaxin-1 and interleukin-34 levels in obsessive-compulsive disorder: a case-control observational study in Bangladesh
Objectives: Obsessive-compulsive disorder (OCD) is a prevalent mental health condition that impacts daily life. It is thought to be associated with genetic, biological, and structural brain changes, serotonergic abnormalities, altered neuromodulation, and environmental factors. Limited observational studies have examined cytokines in Bangladeshi patients with OCD. This study aimed to assess the levels of eotaxin-1 and interleukin (IL)-34 in individuals with this disorder.Methods: This case-control observational study included 58 patients with OCD and 30 healthy controls (HCs) matched for age, sex, and body mass index. The severity of OCD was assessed using the Yale-Brown obsessive-compulsive scale (Y-BOCS). Psychiatrists evaluated participants according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Serum levels of eotaxin-1 and IL-34 were measured using enzyme-linked immunosorbent assay kits.Results: Patients with OCD exhibited significantly higher serum eotaxin-1 levels (121.13±7.84 pg/mL) than HCs (85.52±9.42 pg/mL). Conversely, IL-34 levels were considerably lower in patients than in HCs (119.02±14.53 pg/mL vs. 179.96±27.88 pg/mL). The Cohen d values for eotaxin-1 and IL-34 were 0.55 and −0.48, respectively. Among patients with OCD, a significant positive correlation was found between serum eotaxin-1 level and Y-BOCS score, along with a negative correlation between serum eotaxin-1 and IL-34 levels.Conclusion: The findings suggest that altered eotaxin-1 and IL-34 levels may be associated with OCD. These chemokines and cytokines could serve as primary tools for assessing the risk of OCD, warranting further clinical investigation. This could potentially support more extensive research and the development of diagnostic and therapeutic strategies targeting these pathways.
- 28 February 2025
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 16 (1) , 72-80
Open AccessAltered eotaxin-1 and interleukin-34 levels in obsessive-compulsive disorder: a case-control observational study in Bangladesh
Objectives: Obsessive-compulsive disorder (OCD) is a prevalent mental health condition that impacts daily life. It is thought to be associated with genetic, biological, and structural brain changes, serotonergic abnormalities, altered neuromodulation, and environmental factors. Limited observational studies have examined cytokines in Bangladeshi patients with OCD. This study aimed to assess the levels of eotaxin-1 and interleukin (IL)-34 in individuals with this disorder.Methods: This case-control observational study included 58 patients with OCD and 30 healthy controls (HCs) matched for age, sex, and body mass index. The severity of OCD was assessed using the Yale-Brown obsessive-compulsive scale (Y-BOCS). Psychiatrists evaluated participants according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Serum levels of eotaxin-1 and IL-34 were measured using enzyme-linked immunosorbent assay kits.Results: Patients with OCD exhibited significantly higher serum eotaxin-1 levels (121.13±7.84 pg/mL) than HCs (85.52±9.42 pg/mL). Conversely, IL-34 levels were considerably lower in patients than in HCs (119.02±14.53 pg/mL vs. 179.96±27.88 pg/mL). The Cohen d values for eotaxin-1 and IL-34 were 0.55 and −0.48, respectively. Among patients with OCD, a significant positive correlation was found between serum eotaxin-1 level and Y-BOCS score, along with a negative correlation between serum eotaxin-1 and IL-34 levels.Conclusion: The findings suggest that altered eotaxin-1 and IL-34 levels may be associated with OCD. These chemokines and cytokines could serve as primary tools for assessing the risk of OCD, warranting further clinical investigation. This could potentially support more extensive research and the development of diagnostic and therapeutic strategies targeting these pathways.
- Open Access
- 20 July 2022
- Published by Wiley in Health Science Reports
- Vol. 5 (4) , e734
Community‐based decentralized mental health services are essential to prevent the epidemic turn of post‐Covid mental disorders in Bangladesh: A call to action
- 20 July 2022
- Published by Wiley in Health Science Reports
- Vol. 5 (4) , e734
Open AccessCommunity‐based decentralized mental health services are essential to prevent the epidemic turn of post‐Covid mental disorders in Bangladesh: A call to action
- Open Access
- 11 January 2019
- Published by Springer Nature in Cureus
- Vol. 11 (1) , e3868
Evaluation of Serum Interleukin-6 and C-reactive Protein Levels in Drug-naïve Major Depressive Disorder Patients
Major depressive disorder (MDD) is a disabling health problem with a very high global prevalence and burden. Alteration of inflammatory markers in depression is of growing interest to many psychiatry researchers. This study aimed to examine the serum levels of interleukin-6 (IL-6) and C-reactive protein (CRP) in MDD patients to find out their association with depression. The present study recruited 88 MDD patients and 86 control subjects matched by age, gender, and body mass index (BMI). The Hamilton depression rating scale (Ham-D) was used on all patients to measure their severity of depression. Serum levels of IL-6 and CRP were analyzed by commercially available enzyme-linked immunosorbent assay (ELISA) kits (Abcam, Cambridge, MA, USA). The mean values of serum levels of IL-6 and CRP were 2.94 ± 0.12 pg/mL and 0.99 ± 0.02 mg/L for the patient group and 2.42 ± 0.21 pg/mL and 1.09 ± 0.06 mg/L for the control group, respectively. We found significantly elevated concentrations of serum IL-6 in MDD patients compared with control subjects (p < 0.001). However, the alteration of serum CRP levels was not significant between the groups (p = 0.126). Ham-D scores of patients were positively correlated with serum IL-6 (r = 0.552; p = 0.004) and CRP (r = 0.621; p < 0.001) levels. Moreover, serum IL-6 and CRP levels were observed to be positively correlated (r = 0.452; p = 0.043) with each other in depression. The present study suggests that increased serum IL-6 level might be a contributing factor to the pathogenesis of depression.
- 11 January 2019
- Published by Springer Nature in Cureus
- Vol. 11 (1) , e3868
Open AccessEvaluation of Serum Interleukin-6 and C-reactive Protein Levels in Drug-naïve Major Depressive Disorder Patients
Major depressive disorder (MDD) is a disabling health problem with a very high global prevalence and burden. Alteration of inflammatory markers in depression is of growing interest to many psychiatry researchers. This study aimed to examine the serum levels of interleukin-6 (IL-6) and C-reactive protein (CRP) in MDD patients to find out their association with depression. The present study recruited 88 MDD patients and 86 control subjects matched by age, gender, and body mass index (BMI). The Hamilton depression rating scale (Ham-D) was used on all patients to measure their severity of depression. Serum levels of IL-6 and CRP were analyzed by commercially available enzyme-linked immunosorbent assay (ELISA) kits (Abcam, Cambridge, MA, USA). The mean values of serum levels of IL-6 and CRP were 2.94 ± 0.12 pg/mL and 0.99 ± 0.02 mg/L for the patient group and 2.42 ± 0.21 pg/mL and 1.09 ± 0.06 mg/L for the control group, respectively. We found significantly elevated concentrations of serum IL-6 in MDD patients compared with control subjects (p < 0.001). However, the alteration of serum CRP levels was not significant between the groups (p = 0.126). Ham-D scores of patients were positively correlated with serum IL-6 (r = 0.552; p = 0.004) and CRP (r = 0.621; p < 0.001) levels. Moreover, serum IL-6 and CRP levels were observed to be positively correlated (r = 0.452; p = 0.043) with each other in depression. The present study suggests that increased serum IL-6 level might be a contributing factor to the pathogenesis of depression.
- 1 October 2016
- Vol. 25 (4) , 669-673
Prevalence of Psychiatric Disorders among Female Juvenile Offenders.
Inmates of Juvenile Developmental Centers are the special group of youth population who are in conflict with law. They are vulnerable to psychiatric illness. The objective of this study was to see the prevalence and type of psychiatric disorders in institutionalized female juvenile offenders and non-offenders of same age, sex and socioeconomic group in the community. The association of mental disorders was examined in 43 female inmates of Juvenile Development Centers and 43 randomly selected comparison subjects in community. One stage-structured assessment of psychopathology was carried out by using a structured and valid Bangla version of the Development and Well-Being Assessment (DAWBA). Development and Well-Being Assessment generated psychiatric diagnosis was assigned based on ICD-10 diagnostic criteria for research. The result revealed that, of those who were in conflict with law, 93% had mental disorder, whereas 14% of non-offenders had psychiatric disorder. Among the offenders with psychiatric disorders, most of them (32.6%) suffered from Major Depressive Disorder (MDD), followed by combined MDD & Post Traumatic Stress Disorder (PTSD). On the other hand, among the non-offenders with psychiatric disorder 9.3% suffered from MDD. It can be concluded that considerable psychiatric disorders are prevalent among the female juvenile offenders with comparison to non-offenders. Broad-based replication study could confirm these findings.
- 1 October 2016
- Vol. 25 (4) , 669-673
Prevalence of Psychiatric Disorders among Female Juvenile Offenders.
Inmates of Juvenile Developmental Centers are the special group of youth population who are in conflict with law. They are vulnerable to psychiatric illness. The objective of this study was to see the prevalence and type of psychiatric disorders in institutionalized female juvenile offenders and non-offenders of same age, sex and socioeconomic group in the community. The association of mental disorders was examined in 43 female inmates of Juvenile Development Centers and 43 randomly selected comparison subjects in community. One stage-structured assessment of psychopathology was carried out by using a structured and valid Bangla version of the Development and Well-Being Assessment (DAWBA). Development and Well-Being Assessment generated psychiatric diagnosis was assigned based on ICD-10 diagnostic criteria for research. The result revealed that, of those who were in conflict with law, 93% had mental disorder, whereas 14% of non-offenders had psychiatric disorder. Among the offenders with psychiatric disorders, most of them (32.6%) suffered from Major Depressive Disorder (MDD), followed by combined MDD & Post Traumatic Stress Disorder (PTSD). On the other hand, among the non-offenders with psychiatric disorder 9.3% suffered from MDD. It can be concluded that considerable psychiatric disorders are prevalent among the female juvenile offenders with comparison to non-offenders. Broad-based replication study could confirm these findings.
- 23 September 2008
- Published by Springer Nature in Biological Trace Element Research
- Vol. 127 (2) , 102-108
Zinc, Manganese, Calcium, Copper, and Cadmium Level in Scalp Hair Samples of Schizophrenic Patients
The purpose of the study was to determine the concentration of trace elements present in scalp hair sample of schizophrenic patients and to find out the relationship between trace elements level and nutritional status or socioeconomic factors. The study was conducted among 30 schizophrenic male patients and 30 healthy male volunteers. Patients were recruited from Bangabandhu Sheikh Mujib Medical University by random sampling. Hair trace element concentrations were determined by flame atomic absorption spectroscopy and analyzed by independent t test, Pearson’s correlation analysis, regression analysis, and analysis of variance (ANOVA). Mn, Zn, Ca, Cu, and Cd concentrations of schizophrenic patients were 3.8 ± 2.31 μg/gm, 171.6 ± 59.04 μg/gm, 396.23 ± 157.83 μg/gm, 15.40 ± 5.68 μg/gm, and 1.14 ± 0.89 μg/gm of hair sample, while those of control subjects were 4.4 ± 2.32 μg/gm, 199.16 ± 27.85 μg/gm, 620.9 ± 181.55 μg/gm, 12.23 ± 4.56 μg/gm, and 0.47 ± 0.32 μg/gm of hair sample, respectively. The hair concentration of Zn and Ca decreased significantly (p = 0.024; p = 0.000, respectively) and the concentration of Cu and Cd increased significantly (p = 0.021; p = 0.000, respectively) in schizophrenic patients while the concentration of Mn (p = 0.321) remain unchanged. Socioeconomic data reveals that most of the patients were poor, middle-aged and divorced. Mean body mass indices (BMIs) of the control group (22.26 ± 1.91 kg/m2) and the patient group (20.42 ± 3.16 kg/m2) were within the normal range (18.5−25.0 kg/m2). Pearson’s correlation analysis suggested that only Ca concentration of patients had a significant positive correlation with the BMI (r = 0.597; p = 0.000) which was further justified from the regression analysis (R 2 = 44%; t = 3.59; p = 0.002) and one-way ANOVA test (F = 3.62; p = 0.015). A significant decrease in the hair concentration of Zn and Ca as well as a significant increase in the hair concentration of Cu and Cd in schizophrenic patients than that of its control group was observed which may provide prognostic tool for the diagnosis and treatment of this disease. However, further work with larger population is suggested to examine the exact correlation between trace element level and the degree of disorder.
- 23 September 2008
- Published by Springer Nature in Biological Trace Element Research
- Vol. 127 (2) , 102-108
Zinc, Manganese, Calcium, Copper, and Cadmium Level in Scalp Hair Samples of Schizophrenic Patients
The purpose of the study was to determine the concentration of trace elements present in scalp hair sample of schizophrenic patients and to find out the relationship between trace elements level and nutritional status or socioeconomic factors. The study was conducted among 30 schizophrenic male patients and 30 healthy male volunteers. Patients were recruited from Bangabandhu Sheikh Mujib Medical University by random sampling. Hair trace element concentrations were determined by flame atomic absorption spectroscopy and analyzed by independent t test, Pearson’s correlation analysis, regression analysis, and analysis of variance (ANOVA). Mn, Zn, Ca, Cu, and Cd concentrations of schizophrenic patients were 3.8 ± 2.31 μg/gm, 171.6 ± 59.04 μg/gm, 396.23 ± 157.83 μg/gm, 15.40 ± 5.68 μg/gm, and 1.14 ± 0.89 μg/gm of hair sample, while those of control subjects were 4.4 ± 2.32 μg/gm, 199.16 ± 27.85 μg/gm, 620.9 ± 181.55 μg/gm, 12.23 ± 4.56 μg/gm, and 0.47 ± 0.32 μg/gm of hair sample, respectively. The hair concentration of Zn and Ca decreased significantly (p = 0.024; p = 0.000, respectively) and the concentration of Cu and Cd increased significantly (p = 0.021; p = 0.000, respectively) in schizophrenic patients while the concentration of Mn (p = 0.321) remain unchanged. Socioeconomic data reveals that most of the patients were poor, middle-aged and divorced. Mean body mass indices (BMIs) of the control group (22.26 ± 1.91 kg/m2) and the patient group (20.42 ± 3.16 kg/m2) were within the normal range (18.5−25.0 kg/m2). Pearson’s correlation analysis suggested that only Ca concentration of patients had a significant positive correlation with the BMI (r = 0.597; p = 0.000) which was further justified from the regression analysis (R 2 = 44%; t = 3.59; p = 0.002) and one-way ANOVA test (F = 3.62; p = 0.015). A significant decrease in the hair concentration of Zn and Ca as well as a significant increase in the hair concentration of Cu and Cd in schizophrenic patients than that of its control group was observed which may provide prognostic tool for the diagnosis and treatment of this disease. However, further work with larger population is suggested to examine the exact correlation between trace element level and the degree of disorder.